📰 Dzintars Gotham News
Dzintars Gotham News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dzintars Gotham. Real-time updates on events, politics, business and more.
October 24, 2021
(CNN)During the global scramble to secure vaccines, many countries in Asia-Pacific were slow off the mark. This time, theyre not making the same mistake. Countries around the region are rushing t...
October 18, 2021
Merck is seeking US Food and Drug Administration emergency use authorization for the drug Molnupiravir -- and if its granted, the capsule will become the first oral antiviral treatment against
October 17, 2021
Countries in Asia are placing orders for a new drug to treat coronavirus. Poorer nations could miss out again
October 16, 2021
Merck is set to get $712 per treatment course for its COVID-19 pill from the U.S. government—even as ...
October 13, 2021
According to a report by drug pricing experts at the Harvard School of Public Health (HSPH) and King’s College Hospital in London, a five-day course of molnupiravir only costs $17.74 to produce. [...]
October 8, 2021
Molnupiravir, Merck's new COVID-19 pill, developed with $35M in taxpayer NIH/NIAID funding to Emory University, is being sold to the Biden admin at 3,500% markup.
October 6, 2021
A five-day course of Mercks experimental COVID-19 drug, molnupiravir, costs $17.74 to produce but the company is charging the Biden administration $712 for the same amount.
October 5, 2021
The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense.